Lombard Odier Asset Management Europe Ltd acquired a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 12,115 shares of the conglomerate’s stock, valued at approximately $2,308,000.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Meeder Asset Management Inc. acquired a new position in Danaher during the second quarter valued at approximately $44,000. MidFirst Bank acquired a new position in shares of Danaher during the 2nd quarter worth approximately $46,000. Bell Investment Advisors Inc bought a new stake in shares of Danaher during the 2nd quarter worth approximately $47,000. Fiduciary Financial Advisors acquired a new stake in shares of Danaher in the 2nd quarter valued at approximately $53,000. Finally, Solstein Capital LLC bought a new position in shares of Danaher in the second quarter valued at $58,000. Institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
NYSE DHR opened at $216.41 on Friday. The stock has a market cap of $152.13 billion, a PE ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a 50-day moving average of $199.46 and a 200-day moving average of $192.52. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.
Wall Street Analysts Forecast Growth
DHR has been the topic of several analyst reports. Citigroup assumed coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. Guggenheim decreased their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. DZ Bank began coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price on the stock. Finally, Piper Sandler began coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $228.91.
Read Our Latest Stock Analysis on DHR
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
